HLA-A and endometrial serous adenocarcinoma: First, we measured the response of TCR4-transduced T cells to a patient-derived xenograft (PDX) generated from an HLA-A*03:01+ patient with Mut PIK3CA uterine serous carcinoma (PDX USC_X10) (Extended Data Fig. 6a).